Literature DB >> 35746928

Noninvasive Delivery of Biologicals to the Brain.

Sheldon Jordan1, Margaret Zielinski1, Marcin Kortylewski1, Taylor Kuhn1, Alexander Bystritsky1.   

Abstract

In the past, psychotherapy and neuropharmacological approaches have been the most common treatments for disordered thoughts, moods, and behaviors. One new path of brain therapeutics is in the deployment of noninvasive approaches designed to reprogram brain function at the cellular level. Treatment at the cellular level may be considered for a wide array of disorders, ranging from mood disorders to neurodegenerative disorders. Brain-targeted biological therapy may provide minimally invasive and accurate delivery of treatment. The present article discusses the hurdles and advances that characterize the pathway to this goal.
Copyright © 2022 by the American Psychiatric Association.

Entities:  

Keywords:  Neuroimaging - PS0398; Pharmacokinetics - AJP0064; biological therapy; brain-targeted; non-invasive

Year:  2022        PMID: 35746928      PMCID: PMC9063603          DOI: 10.1176/appi.focus.20210028

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN: 1541-4094


  105 in total

Review 1.  Recent advancements in liposome technology.

Authors:  Nina Filipczak; Jiayi Pan; Satya Siva Kishan Yalamarty; Vladimir P Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2020-06-25       Impact factor: 15.470

Review 2.  Ultrasound Technologies for Imaging and Modulating Neural Activity.

Authors:  Claire Rabut; Sangjin Yoo; Robert C Hurt; Zhiyang Jin; Hongyi Li; Hongsun Guo; Bill Ling; Mikhail G Shapiro
Journal:  Neuron       Date:  2020-10-14       Impact factor: 17.173

Review 3.  Opportunity and challenges of nasal powders: Drug formulation and delivery.

Authors:  Laura Tiozzo Fasiolo; Michele Dario Manniello; Elena Tratta; Francesca Buttini; Alessandra Rossi; Fabio Sonvico; Fabrizio Bortolotti; Paola Russo; Gaia Colombo
Journal:  Eur J Pharm Sci       Date:  2017-09-20       Impact factor: 4.384

4.  Theta burst TMS increases cerebral blood flow in the primary motor cortex during motor performance as assessed by arterial spin labeling (ASL).

Authors:  Ariane Orosz; Kay Jann; Miranka Wirth; Roland Wiest; Thomas Dierks; Andrea Federspiel
Journal:  Neuroimage       Date:  2012-04-12       Impact factor: 6.556

5.  Membrane Voltage Is a Direct Feedback Signal That Influences Correlated Ion Channel Expression in Neurons.

Authors:  Joseph M Santin; David J Schulz
Journal:  Curr Biol       Date:  2019-05-09       Impact factor: 10.834

6.  A Novel Peptide-Equipped Exosomes Platform for Delivery of Antisense Oligonucleotides.

Authors:  Huiying Xu; Chong Liao; Shifu Liang; Bang-Ce Ye
Journal:  ACS Appl Mater Interfaces       Date:  2021-02-23       Impact factor: 9.229

7.  Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease.

Authors:  Aline Delva; Donatienne Van Weehaeghe; Michel Koole; Koen Van Laere; Wim Vandenberghe
Journal:  Mov Disord       Date:  2020-08-07       Impact factor: 10.338

8.  Pulsed Focal Ultrasound as a Non-Invasive Method to Deliver Exosomes in the Brain/Stroke.

Authors:  Ahmet Alptekin; Mohammad B Khan; Roxan Ara; Mohammad H Rashid; Fengchong Kong; Mahrima Parvin; Joseph A Frank; Rajiv Chopra; Krishnan Dhandapani; Ali S Arbab
Journal:  J Biomed Nanotechnol       Date:  2021-06-01       Impact factor: 4.099

9.  Recombinant Peptide Production Platform Coupled with Site-Specific Albumin Conjugation Enables a Convenient Production of Long-Acting Therapeutic Peptide.

Authors:  Mijeong Bak; Junyong Park; Kiyoon Min; Jinhwan Cho; Jihyoun Seong; Young S Hahn; Giyoong Tae; Inchan Kwon
Journal:  Pharmaceutics       Date:  2020-04-16       Impact factor: 6.321

Review 10.  Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.

Authors:  Yong Fan; Shi-Yan Ng
Journal:  Transl Neurodegener       Date:  2020-01-07       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.